SYDNEY, June 10, 2026, 04:03 AEST
- Ramsay Health Care added 2.79% to A$37.64 on Tuesday, ahead of the S&P/ASX 200, which slipped 0.24%.
- The ASX cash market was shut at the dateline cutoff. Regular hours are 09:59:45 through 16:00 in Sydney, then the closing auction.
- Investors look at Ramsay’s better first-half Australian hospital performance while also dealing with cost pressures, uncertainty in the UK, and the scheduled separation of Ramsay Santé.
Ramsay Health Care Limited gained on Tuesday while the main Australian index fell. Healthcare stocks drew buyers during a session that saw mining shares drag the market lower.
Hospital operator shares finished A$1.02 higher at A$37.64, up 2.79%. The stock moved from A$36.39 to A$37.65 during the session, according to market data. The S&P/ASX 200 lost 0.24% in Sydney. Losses in gold, metals and mining stocks offset gains in other sectors.
Ramsay traded higher, lifted by demand for defensive names — meaning stocks seen as less tied to swings in the economy. CSL and ResMed gained too. On the other side, BHP and Fortescue weighed on the index, with commodities names losing ground.
ASX 200 pares earlier losses after rough open. TradingView, using Trading Economics numbers, reported the index closed at 8,604 after new data pointed to another dip in consumer confidence for June, while business sentiment stayed sluggish.
Matthew Hassan, who leads Australian macro-forecasting at Westpac, said the latest consumer sentiment data is “back amongst the weakest seen” since the survey began 50 years ago. NAB economist Michael Hayes said business confidence “remains very weak” because of continued cost pressure. Reuters
Investors didn’t see any clear new company trigger in the last 24 hours. The move pushed focus back on Ramsay’s half-year numbers from February, and whether the market still thinks its Australian hospitals are able to balance out softer results in other regions.
Ramsay posted first-half revenue of A$9.3 billion, a 9.7% increase, and underlying EBIT of A$536.7 million, up 7.3%. The company defines underlying EBIT as earnings before interest and tax, excluding one-off or non-core items. Underlying net profit after tax was up 8.1% at A$171.7 million. Ramsay lifted its interim dividend 6.3% to 42.5 Australian cents per share.
Australia was the main driver. Ramsay’s Australian underlying EBIT climbed 7.1% to A$330.9 million. Ramsay Santé’s underlying EBIT rose 14.2% to A$116.7 million. The Elysium mental health arm in the UK went the other way, with weaker numbers, showing the portfolio isn’t moving in sync everywhere.
The European side is still key for the stock’s story. Ramsay Santé, where Ramsay holds a 52.79% stake, reported back in May that revenue for the nine months climbed 3.1% to €3.98 billion. EBITDA was up 4.4%, coming in at €460.4 million. EBITDA—earnings before interest, tax, depreciation and amortisation—is often used to track cash generation. CEO Pascal Roché said the results showed the “continued strength of our model.” GlobeNewswire
Ramsay Santé’s planned separation is still the main overhang here. Ramsay pointed to an in-specie distribution in its half-year presentation, aiming to finish by the end of 2026 but needing shareholder approval first. Ramsay Santé in a separate note pointed out Ramsay’s idea to give out its 52.79% stake to shareholders, though it said Ramsay was still looking at other options.
The rally isn’t without risks. Higher wage bills, more funding stress in France, or a softer UK business could hit Ramsay’s margin recovery. A slow or disorderly Ramsay Santé split might leave investors fixated on structure over hospital profits.
Ramsay’s next date on the calendar is its FY26 results, due Aug. 27. The company is set to pay an ordinary-share dividend on Sept. 24, with its 2026 annual meeting booked for Nov. 24, according to its investor site.
